Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Omada Health (OMDA) Cost of Revenue (2024 - 2026)

Omada Health's Cost of Revenue history spans 2 years, with the latest figure at $23.0 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 35.37% to $23.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $83.9 million, a N/A change, with the full-year FY2025 number at $90.0 million, up 34.55% from a year prior.
  • Cost of Revenue hit $23.0 million in Q4 2025 for Omada Health, roughly flat from $22.9 million in the prior quarter.
  • Over the last five years, Cost of Revenue for OMDA hit a ceiling of $23.0 million in Q4 2025 and a floor of $15.2 million in Q2 2024.